Macrophage Perspectives in Liver Diseases: Programmed Death, Related Biomarkers, and Targeted Therapy
Overview
Molecular Biology
Affiliations
Macrophages, as important immune cells of the organism, are involved in maintaining intrahepatic microenvironmental homeostasis and can undergo rapid phenotypic changes in the injured or recovering liver. In recent years, the crucial role of macrophage-programmed cell death in the development and regression of liver diseases has become a research hotspot. Moreover, macrophage-targeted therapeutic strategies are emerging in both preclinical and clinical studies. Given the macrophages' vital role in complex organismal environments, there is tremendous academic interest in developing novel therapeutic strategies that target these cells. This review provides an overview of the characteristics and interactions between macrophage polarization, programmed cell death, related biomarkers, and macrophage-targeted therapies. It aims to deepen the understanding of macrophage immunomodulation and molecular mechanisms and to provide a basis for the treatment of macrophage-associated liver diseases.
He C, Jiang M, Xiong Q, Huang Z Sci Rep. 2025; 15(1):5814.
PMID: 39962185 PMC: 11833071. DOI: 10.1038/s41598-025-90155-4.
Current Treatment Regimens and Promising Molecular Therapies for Chronic Hepatobiliary Diseases.
Durazzo M, Ferro A, Navarro-Tableros V, Gaido A, Fornengo P, Altruda F Biomolecules. 2025; 15(1).
PMID: 39858515 PMC: 11763965. DOI: 10.3390/biom15010121.